PubMed Health⌕ Search

PubMed · 8821712

Creatine kinase activity decrease with short-term freezing.

Abstract

Freezing of serum samples at -30 degrees C without protective agents is the simplest and least expensive method of storage in serum banks. We investigated the stability of creatine kinase (CK) in human sera after freezer storage under such conditions for 24 h (n = 30) or for 2 or 4 weeks (n = 99). CK activity was measured in fresh sera and compared to matched thawed sera after freezer storage at the designated time intervals. The enzyme's median activity decreased significantly after 24 h, 2 weeks, and 4 weeks of freezer storage by 2.6, 5.9, and 8.3%, respectively (p < 0.0001, r = 0.99). Sex or high CK initial values had no significant effect on these results. We conclude that freezer storage of serum at -30 degrees C, even for short periods, causes a steady and significant decline in CK activity. These results should be taken into consideration when analyzing CK activity in frozen sera for research or clinical purposes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E I Lev, I Hendler, R Siebner, Z Tashma, M Wiener, I Tur-Kaspa. Creatine kinase activity decrease with short-term freezing.. https://doi.org/10.1159/000474994

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Under pressure.

Explore the source record for details and available documents.

Blood Banks↗

Detection of West Nile virus in blood donations--United States, 2003.

During the 2002 epidemic of West Nile virus (WNV) in the United States, a total of 23 persons were reported to have acquired WNV infection after receipt of blood components from 16 WNV-viremic blood donors, and an estimated 500 viremic donations might have been collected (B. Biggerstaff, M.D., CDC, personal communication, 2003). Because of the possibility of recurrent WNV epidemics in the United States, blood collection agencies (BCAs) recently implemented WNV nucleic acid--amplification tests (NATs) to screen all donations and quarantine and retrieve potentially infectious blood components. In addition to NAT screening, the Food and Drug Administration (FDA) recommended that BCAs enhance donor deferral questions by specifically asking about fever with headache occurring in the week before donation and defer persons reporting such symptoms. This report describes the NAT screening process for two WNV-viremic donors and presents data summarizing the testing results for approximately 95% of the civilian blood donations collected during late June to early August. These preliminary data suggest that investigational screening tests are effective in identifying viremic donations and preventing the implicated blood components from entering the blood supply.

Blood Banks↗

[Hemovigilance: a joint responsibility of hospitals and blood banks].

The objective of haemovigilance, a set of surveillance procedures covering the complete transfusion chain, is to collect and assess information concerning unexpected and undesirable effects arising from the therapeutic use of labile blood products, and to prevent the recurrence of such incidents. A number of guidelines and directives from national and European health authorities require hospitals to institute a haemovigilance system. Preliminary data from one blood bank region in the Netherlands reveals the various types of transfusion reactions reported. The current haemovigilance systems still have some limitations. A considerable amount of time and effort will be needed for the benefits of haemovigilance to become apparent.

Blood Banks↗